New Report: New Incentives for Physicians to Prescribe Biosimilars Would Improve Affordability
April 15, 2016
(Washington, D.C.)—Incentives for physicians to prescribe biosimilars could increase utilization and reduce costs, according to a new report — “Payor...
PCMA Statement on New IMS Health Drug Spending Report
April 14, 2016
(Washington, D.C.)— Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on a new...
PCMA “PBM Policy Forum” Tackles Prescription Drug Pricing Debate
April 11, 2016
(Washington, D.C.)—Today, the Pharmaceutical Care Management Association (PCMA) holds its annual “PBM Policy Forum” at the Newseum in Washington, D.C....
PCMA Statement on the FDA’s Decision to Approve the Second U.S. Biosimilar
April 06, 2016
(Washington, D.C.)—Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on yesterday’s decision by the...
PCMA Launches New Campaign: ‘That’s What PBMs Do’
March 17, 2016
(Washington D.C.)— As policymakers seek solutions to combat high drug prices, the Pharmaceutical Care Management Association (PCMA) is launching a...
Researchers Find Home Delivery of Medications Improves Adherence for Stroke Patients
February 25, 2016
Stroke patients receiving medication through mail-service pharmacies have better adherence than those getting their medication at drugstores, according to a...
PBMs Provide Policy Solutions to Increase Competition, Reduce Rx Costs
February 04, 2016
(Washington, D.C.)— Testifying before the House Committee on Oversight and Government Reform, Pharmaceutical Care Management Association (PCMA) President and CEO...